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The processing of amino-terminal methionine from cytosolic proteins in E. coli has been investigated in vivo, using amino-terminal-extended human 
growth hormone (hGH) as a model system. Twenty different hGH-genes with the sequence Met-Xxx-Glu-Glu-hGH where Xxx denotes each of 
the 20 different amino acids, were constructed and expressed in E. coli. Following purification of the products, the N-terminal amino acid sequences 
(10 cycles) were determined. The results demonstrate that the removal of methionine is dependent on the amino acid adjacent to methionine, and 
that the processing is strongly correlated to the radius of gyration of this amino acid. In addition, measurement of the hGH expression level from 
the 20 clones demonstrated that the small difference in the amino acid extension leads to a change in the specific hGH expression rate. 
Processing, in vivo; Methionyl aminopeptidase; Amino-terminal-extended human growth hormone 
I .  INTRODUCTION In the present work, an analysis of the influence of 
the amino acid adjacent to the methionine on the pro- 
Protein synthesis in E. coli is under normal cir- cessing capacity is described. 
cumstances initiated at the translation initiation codon 
AUG which codes for the amino acid, methionine. As 2. MATERIALS AND METHODS 
a consequence, the newly synthesized protein has as its 
N-terminal amino acid a methionyl residue. 
E. coli possesses an enzyme activity in the cytoplasm 
with the capacity to remove N-terminal methionine. 
However, in vivo and in vitro experiments have 
demonstrated that the enzyme has some limitations and 
that processing is dependent on the amino acid adjacent 
to methionine [1,2]. 
When synthesising recombinant proteins of phar- 
maceutical interest, it is of the utmost importance that 
the final product has an N-terminal identical to the 
naturally occurring counterpart, as it otherwise may 
have antigenic properties. The correct removal of 
methionine is therefore of great concern. 
Recently we reported a new method.for the produc- 
tion of recombinant interleukin-1 and human growth 
hormone (hGH) with the correct N-termini [3,4]. The 
proteins are produced as precursors, N-terminally ex- 
tended with a few amino acids and are subsequently 
converted to the correct molecules by an enzymatic pro- 
cess in vitro. However, the method requires that the ex- 
tension has an even number of amino acids, typically 2 
or 4, and we were therefore especially interested in 
whether the N-terminal methionine is removed in vivo 
or not. 
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2.1. Construction of hGH expression vectors 
The hGH expression vectors were constructed from the plasmid 
pHD86-3SP13 (41. The plasmid was cut with CluI/EcoRI, purified by 
gel electrophoresis and ligated to new synthetic linkers encoding the 
20 different amino-terminal extensions (Table 1). The linkers were 
designed to have Clul/EcoRI overhangs: 
( C G A T G  X X X  G A A  G 
T A C  X X X  C T T  C T T A A )  
The correct DNA sequence of the individual linkers was verified after 
cloning, directly on the plasmid by use of a synthetic primer com- 
plementary to a part of the promoter sequence. E. coli hIC1061 15) 
harbouring the expression plasmids was propagated in 50 ml TB 
medium containing 50 mg ampicillin/litre. The cultures were started 
from an overnight culture at an ODsm = -0.2 and incubated in a 
shaker (250 rpm) at 30°C. Samples (1 ml) were collected in duplicate 
from each culture at time intervals of 2 ,4 ,6  and 18 h. ODsm and the 
contents of hGH were determined in each sample using a hGH- 
specific ELISA [6]. Following growth for 18 h (overnight samples), 
cells were harvested by centrifugation, resuspended in 5 ml of 10 mhl 
Tris-HC1, pH 7.5, 50 mhl EDTA, and sonicated on ice (4 x 30 s). 
2.2. Purification of amino-terminal-extended hGH 
The cell extracts were centrifuged and the resulting supernatants 
were dialysed for 18 h against 200 vols of 25 mhl Tris-HC1, pH 7.5. 
The dialysed extracts were loaded on a DEAE-Sepharose column 
(Pharmacia) (0.8 cm2 x 5 cm), and equilibrated with 25 mhl Tris-CI, 
pH 7.5. The column was washed with 10 ml of the above buffer, and 
the hGH eluted with 100 ml buffer containing NaCl in a gradient 
from 0 to 200 mhl. The fractions containing hGH were pooled. 
50-200 pmol of each sample were separated by SDS-PAGE [7], and 
electroblotted onto lmmobilon PVDF membranes (Millipore) [8]. 
After transfer, proteins were stained with 0.1% Coomassie blue R250 
in 10'70 acetic acid. The protein bands corresponding to amino- 
terminal-extended hGH were excised and stored at -20°C in an 
argon atmosphere until sequence analysis. 
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Table I 
DNA and amino acid sequence of the amino terminal-extension of 
the 20 different clones 
Clone 
pHD2Ol 
pHD107 
pHD202 
pHD212 
pHD2l l 
pHDI 18 
pHD203 
pHD2OS 
Encoded N-terminus 
- -- 
Linker DNA sequence 
Met-Gly-Glu-Glu 
Met-Ala-Glu-Glu 
hlet-Ser-Glu-Glu 
Met-Tyr-Glu-Glu 
hlet-Cys-Glu-Glu 
hfet-Thr-Glu-Glu 
Met-Pro-Glu-Glu 
Met-Val-Glu-Glu 
Met-Asp-Glu-Glu 
Met-Asn-Glu-Glu 
Met-Leu-Glu-Glu 
Met-Ile-Glu-Glu 
Met-Gln-Glu-Glu 
Met-Glu-Glu-Glu 
Met-His-Glu-Glu 
Met-Met-Glu-Glu 
Met-Phe-Glu-Glu 
Met-Lys-Glu-Glu 
Met-Trp-Glu-Glu 
ATGGGTGAAGAA 
ATG GCT GAA GAA 
ATG TCT GAA GAA 
ATGTACGAAGAA 
ATG TGC GAA GAA 
ATGACCGAAGAA 
ATG CCG GAA GAA 
ATG GTT GAA GAA 
ATG GAC GAA GAA 
ATG AAC GAA GAA 
ATG CTG GAA GAA 
ATG ATC GAA GAA 
ATG CAG GAA GAA 
ATG GAA GAA GAA 
ATGCACGAAGAA 
ATG ATG GAA GAA 
ATG TTC GAA GAA 
ATG AAA GAA GAA 
ATG TGG GAA GAA 
~ H D Z O O  Met-~ri-Glu-Glu ATG CGT GAA GAA 
2.3. Sequence analysis 
The PVDF membranes containing the hGH samples were subjected 
to automatic Edman degradation using an ABI 477A protein/peptide 
sequencer with on-line analysis of  the released PTH-amino acids. The 
TFA cleavage step was modified so as to incorporate gas-phase 
cleavage instead of liquid phase. This enabled a more positive iden- 
tification o f  the amino acids. All samples contained a background 
level of  amino acids, particularly in the first two cycles of  Edman 
degradation; but this level constituted less than 5% of the relevant N- 
termini. 
3. RESULTS AND DISCUSSION 
Twenty genes expressing amino-terminal-extended 
hGH were constructed. The genes were identical except 
for the amino acid adjacent to the Met (Table I). 
Following expression of the individual hGH genes, cells 
were harvested by centrifugation, opened by sonication 
and recentrifuged. The cleared cell extracts were 
analyzed on native and SDS-PAGE (data not shown) 
and purified by ion-exchange chromatography as 
described in section 2. The hGH contents were deter- 
mined by a hGH-specific ELISA [6] in samples col- 
lected from the individual cell clones during 
exponential (2 and 4 h samples), early stationary phase 
(6 h samples) and late stationary growth phase. The ex- 
pression was found to be approximately 5-10pg/ml 
(OD600 = 1) in the 18 h samples, except for the clone 
pHD205 and pHD212 which both expressed approx- 
imately 1 pg/ml (OD600 = 1). 
Although the contents of hGH per cell (except for the 
two clones mentioned above) were in the same order of 
magnitude, there was a significant difference in the 
specific production of hGH per cell between the in- 
dividual clones. The reason(s) for this difference which 
was observed both in the exponential growth phase and 
in the early and late stationary growth phase, is not ob- 
vious, but factors such as codon usage, secondary 
structures or stability of either the mRNA or  the pro- 
duct may account for the observed differences. It could 
also be expected that processing of the methionine 
could have some influence on the hGH production 
level. However, as no correlation between processing of 
the methionine and the final hGH contents is observed, 
this is probably not the case. 
The ratio of hGH per cell between the exponential 
growth phase, and the late stationary phase (18 h 
samples), was, for most of the clones, between 2 and 4. 
Plasmids such as pBR322 or derivatives as used in this 
study, are known to increase their copy number per cell 
when the growth rate declines; thus the above- 
mentioned difference in hGH per cell between the ex- 
ponentially and stationary cells may be explained by an 
increase in plasmid copy number. 
In a recently published paper [12], 3 of the clones 
(pHD115, pHD116, pHD118) were compared under 
various controlled growth conditions in fermentors. 
This resulted in essentially the same observations of dif- 
ferences in expression levels between the clones 
reported here, and it is concluded that the differences 
are related to the small changes in the N-terminal 
regions. 
The purified hGH samples were subjected to N- 
terminal analysis by automatic Edman degradation. 
The results are presented in Table 11. The processing of 
the methionine residues is in accordance with the inter- 
pretation that this amino acid is only cleaved if the ad- 
jacent amino acid has a relatively small side chain. 
Others have shown that the radius of gyration [ l l ]  has 
to  be 1.43 A or less, preferably smaller than 1.29 A in 
order to  allow for processing of the Met in yeast 
[1,2,9]. However, in our experiments, processing was 
also found to take place if the radius of gyration was 
larger than 1.43 A, as seen for Gln 1.75 A, Ile 1.56 A 
and Met 1.80 A. 
If the radius of gyration is the sole factor in deter- 
mining the processing capacity of the enzyme, it would 
be expected that, for example, processing at Ala 
(0.77 A) would be more efficient than at the Ser 
(1.08 A) or Cys (1.22 A). This does not seem to be the 
case as 100% processing is observed at the Met-Ser and 
Met-Cys, thus implying that the enzyme, although 
dependent on the radius of gyration of the adjacent 
amino acid, may have some additional preferences. The 
various hGH molecules differ from each other by only 
one amino acid, and this change may alter the 
solubilization properties or the charge of the protein, 
thus affecting the processing by making the protein less 
accessible to the enzyme. We have shown earlier that 
the processing capacity can be 'overloaded' if the ex- 
pression level of hGH is high [4]. Since the expression 
levels of e.g. Met-Ala-Glu-Glu-hGH, Met-Thr-Glu- 
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Table I1 
Comparison of the 20 different clones 
Clone Encoded Gyration radius Expression level Observed N-terminus 
N-terminus of amino acid mg/ml O D ~ O O =  1 (% molecules with 
adjacent to hlet Exp./overnight N-terminal Met) 
(A) [ I l l  This reporthef. [lo] 
pHD204 hlet-Gly-Glu-Glu 0.00 0.7/3.7 0/3 
pHD107 hlet-Ala-Glu-Glu 0.77 1.1/4.6 5 /4 
pHD202 hlet-Ser-Glu-Glu 1.08 2.4/8.7 0/6 
pHD2l l hlet-Cys-Glu-Glu 1.22 2.6B.O 0/19 
pHDI I8 hlet-Thr-Glu-Glu 1.24 3.3/5.4 10/10 
pHD203 Met-Pro-Glu-Glu 1.25 2.1/8.7 5/12 
pHD205 Met-Val-Glu-Glu 1.29 0.3/1.2 10/12 
pHD2lO hlet-Asp-Glu-Glu 1.43 1.2/5.7 100/84 
pHD207 Met-Asn-Glu-Glu 1.45 1.8/6.1 100/84 
pHD2Ol Met-Leu-Glu-Glu 1.54 2.5/6.6 100/84 
pHD213 hlet-Ile-Glu-Glu 1.56 3.6/4.9 90182 
pHD208 hlet-Gln-Glu-Glu 1.75 1.4/4.8 40/100 
pHD116 hlet-Glu-Glu-Glu 1.77 0.8/2.6 100/100 
pHD209 Met-His-Glu-Glu 1.78 0.5/5.4 100/100 
pHD214 hlet-hlet-Glu-Glu 1.80 2.0/5.8 60/ 100 
pHDl l5  hlet-Phe-Glu-Glu 1.90 2.9/3.2 100/100 
pHD206 hlet-Lys-Glu-Glu 2.08 3.3/7.1 100/100 
pHD212 Met-Tyr-Glu-Glu 2.13 0.2/0.7 100/100 
2.21 0.7/2.2 100/100 pHD216 Met-Trp-Glu-Glu 
pHD200 hlet-Arg-Glu-Glu 2.38 3.0/9.1 100/100 
Exp. = expression level during exponential growth phase (2 and 4 h samples) 
Glu-hGH, Met-Ser-Glu-Glu-hGH and Met-Gly-Glu- 
Glu-hGH were of the same order of magnitude, but 
heterogeneous N-terminus was only observed for Met- 
Ala-Glu-Glu-hGH and Met-Thr-Glu-Glu-hGH, the ex- 
pression level cannot explain the observed 
heterogeneity. 
Our results on the processing of the methionine are, 
to a great extent, in agreement with the results publish- 
ed by Hirel et al. while this manuscript was in prepara- 
tion [lo]. In their paper, they show that the extent of 
methionine cleavage decreases proportionally to the in- 
crease of minimal side chain length of the amino acid 
adjacent to the methionine. The two sets of results are 
compared in Table 11. 
The greatest difference is seen for Gln (60% process- 
ed in our case vs 0%) and Met (40% vs 0%). The reason 
for this difference in the observed processing is not ob- 
vious, but the use of different model proteins, which 
may result in different secondary structure of the N- 
terminal regions and the use of different expression 
systems, may influence the catalytic events. 
In conclusion, our results demonstrate that although 
dependent on the radius of gyration of the amino acid 
adjacent to the methionine, other factors, such as the 
expression level, the solubilization and charge proper- 
ties of the protein and probably other as yet unknown 
factors, may affect the processing of the N-terminal 
methionine in vivo in E. coli. 
Therefore, before choosing a final process based on 
in vivo processing of the methionine, it has to be con- 
sidered that although processing should occur correct- 
ly, minor amounts of the product may contain 
N-terminal methionine. This 'contaminated' product 
can be difficult to separate from the correct protein in 
the subsequent purification steps and may also have 
undesirable biological side-effects. 
Ackno~vledgemenIs: We thank Heide Heinsoe and Jannie Rosendahl 
Christensen for excellent technical assistance, and Thorkild 
Christensen for the synthesis of DNA linkers. 
REFERENCES 
[I] Tsunasawa, S., Stewart, J.W. and Sherman, F. (1985) J. Biol. 
Chem. 260, 5382-5391. 
[2] Ben-Bassat, A.. Bauer. K., Chang, S.-Y., Myambo, K., 
Boosman, A. and Chang, S. (1987) J. Bacterial. 169,751-757. 
[3] Dalboge, H., Bayne, S., Christensen, T. and Hejnzs, K.R. 
(1989) FEBS Lett. 246, 89-93. 
(41 Dalboge, H., Dahl, H.-H.hl., Pedersen, J., Hansen, J.W. and 
Christensen, T. (1987) Bio/Technology 5, 161-164. 
[S] Casadaban, h1.J. and Cohen, S.N. (1980) J. hlol. Biol. 138, 
170-207. 
[6] Dinesen, B. and Dalboge, H. (1984) Anal. Chirn. Acta 163, 
119-125. 
[7] Laemmli, U.K. (1970) Nature 277, 680-685. 
[8] Matsudaira, P. (1987) J. Biol. Chem. 262, 10035-10038. 
(91 Sherman, F., Stewart, J.W. and Tsunasawa, S. (1985) 
BioEssays 3, 27-31. 
[lo] Hirel, P.H.-H., Schrnitter, J.-hl., Dessen, P., Fayat, G. and 
Blanquet, S. (1989) Proc. Natl. Acad. Sci. USA 86,8247-8251. 
[ I l l  Levitt, hl. (1976) J. hlol. Biol. 104, 59-107. 
[12] Jensen, E.B. and Carlsen, S. (1990) Biotechnol. Bioeng. 35, in 
press. 
